Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ventriol-P
- Development stage
- Unknown
- Lead developer
- Healthkind Labs
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ventriol-P is a fixed-dose combination oral syrup developed and marketed by Healthkind Labs. It contains four active ingredients: terbutaline (a bronchodilator), guaifenesin (an expectorant), bromhexine (a mucolytic), and menthol (a soothing agent). Terbutaline acts as a selective beta-2 adrenergic receptor agonist to relax bronchial smooth muscle and widen the airways. Guaifenesin increases the volume and reduces the viscosity of respiratory tract secretions, facilitating mucociliary clearance. Bromhexine thins and loosens thick phlegm by depolymerizing mucopolysaccharide fibers. Menthol stimulates TRPM8 receptors to produce a cooling sensation and relieve minor throat irritation. Ventriol-P is approved and marketed in India for the symptomatic relief of productive cough associated with bronchospasm, bronchitis, bronchial asthma, emphysema, and other bronchopulmonary disorders.
- Brand names
- Ventriol-P
- Other names
- bromhexine + guaifenesin + menthol + terbutalinebromhexine + guaiphenesin + menthol + terbutalineterbutaline + guaifenesin + menthol + bromhexineterbutaline + guaiphenesin + menthol + bromhexine
02
Targets
ADRB2 (β2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)
Beyond the preview
Go deeper on Ventriol-P.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ventriol-P.